BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• 

  Drug Development

  Celgene Decides to Not Move Forward With Phase III Portion of tnAcity

  December 7, 2016

   · 

  2 min read
• 

  Business

  Cambridge Biotech TCR2 Therapeutics Launches From Stealth Mode With $44.5 Million

  December 7, 2016

   · 

  2 min read
• 

  Policy

  Pfizer Fined a Record $107 Million for Ramping Up Epilepsy Drug Price by as Much as 2,600%

  December 7, 2016

   · 

  3 min read
• 

  Drug Development

  BioPharm Executive: So Long 2016 (and Good Riddance?)

  December 7, 2016

   · 

  8 min read
• Biotech Bay

  Top 8 Jobs for Science Lovers

  December 7, 2016

   · 

  6 min read
• Policy

  Abbott Files Complaint to Abort $5.8 Billion Alere Deal

  December 7, 2016

   · 

  1 min read
• Business

  To Lead The Field Of ALS Treatment Worldwide: Kadimastem Announces Strategic Collaboration With Korean Biotech Company Corestem, Including A $7 Million Investment In Kadimastem

  December 7, 2016

   · 

  7 min read
• Perflow Announces Issuance Of Patent For The Stream Dynamic Neuro-Thrombectomy Net To Improve Thrombus Removal Post-Stroke

  December 7, 2016

   · 

  2 min read
• Job Trends

  This Irish Biotech to Triple Workforce in 2017 and Just Got Backing From U2’s Bono

  December 7, 2016

   · 

  2 min read
• Business

  Neurimmune Therapeutics And TVM Capital Life Science Announce Creation Of AL-S Pharma To Develop Innovative Therapy For Patients With ALS

  December 7, 2016

   · 

  2 min read